Cyclodextrin induces calcium-dependent lysosomal exocytosis
Fannie W Chen, Chunlei Li, Yiannis A Ioannou, Fannie W Chen, Chunlei Li, Yiannis A Ioannou
Abstract
Cyclodextrins (CDs) have long been used to manipulate cellular cholesterol levels both in vitro and in vivo, but their direct effects at a cellular level are not well characterized. Recently, CDs have garnered much interest because of their ability to clear stored cholesterol from Niemann Pick Type C (NPC) cells and markedly prolong the life of NPC1 disease mice. Here, we investigate the hypothesis that treatment with 2-hydroxypropyl- β-cyclodextrin (HPB-CD) stimulates lysosomal exocytosis in a calcium-enhanced manner. We propose that this exocytosis is the mechanism by which HPB-CD ameliorates the endolysosomal cholesterol storage phenotype in NPC cells. These findings have significant implications for the use of HPB-CD in biochemical assays and data interpretation as well as for their use for the treatment for NPC and other disorders.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem. 1989;186:17–22.
- Christian AE, Haynes MP, Phillips MC, Rothblat GH. Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res. 1997;38:2264–2272.
- Ilangumaran S, Hoessli DC. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J. 1998;335(Pt 2):433–440.
- Giocondi MC, Milhiet PE, Dosset P, Le Grimellec C. Use of cyclodextrin for AFM monitoring of model raft formation. Biophys J. 2004;86:861–869.
- Marcus AD. Wall Street J. New York: Dow Jones & Company; 2009. A Mom Brokers Treatment for Her Twins' Fatal Illness.A13
- Camargo F, Erickson RP, Garver WS, Hossain GS, Carbone PN, et al. Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci. 2001;70:131–142.
- Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One. 2009;4:e6951.
- Liu B, Ramirez CM, Miller AM, Repa JJ, Turley SD, et al. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J Lipid Res. 2010;51:933–944.
- Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem. 2006;281:6616–6624.
- Taylor AR, Robinson MB, Gifondorwa DJ, Tytell M, Milligan CE. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev Neurobiol. 2007;67:1815–1829.
- Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19:142–149.
- Kilsdonk EP, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ, et al. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem. 1995;270:17250–17256.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55–63.
- Savina A, Furlan M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003;278:20083–20090.
- Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, et al. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc Natl Acad Sci U S A. 2009;106:2377–2382.
- Jaiswal JK, Chakrabarti S, Andrews NW, Simon SM. Synaptotagmin VII restricts fusion pore expansion during lysosomal exocytosis. PLoS Biol. 2004;2:E233.
- Rodriguez A, Webster P, Ortego J, Andrews N. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol. 1997;137:93–104.
- Dedkova EN, Sigova AA, Zinchenko VP. Mechanism of action of calcium ionophores on intact cells: ionophore-resistant cells. Membr Cell Biol. 2000;13:357–368.
- Langhorst MF, Reuter A, Jaeger FA, Wippich FM, Luxenhofer G, et al. Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2. Eur J Cell Biol. 2008;87:211–226.
- Blanc L, Liu J, Vidal M, Chasis JA, An X, et al. The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: implication for the regulation of cell volume. Blood. 2009;114:3928–3934.
- Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic. 2002;3:321–330.
- Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575–581.
- Laulagnier K, Grand D, Dujardin A, Hamdi S, Vincent-Schneider H, et al. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett. 2004;572:11–14.
- Gould S, Scott RC. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol. 2005;43:1451–1459.
- Wang MS, Boddapati S, Sierks MR. Cyclodextrins promote protein aggregation posing risks for therapeutic applications. Biochem Biophys Res Commun 2009
- Rosenbaum AI, Zhang G, Warren JD, Maxfield FR. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. Proc Natl Acad Sci U S A. 1990;107:5477–5482.
- Lencer WI, Weyer P, Verkman AS, Ausiello DA, Brown D. FITC-dextran as a probe for endosome function and localization in kidney. Am J Physiol. 1990;258:C309–317.
- Begley D. Rockville, MD: Cyclodextrin and the blood-brain barrier; 2010;
- Monnaert V, Tilloy S, Bricout H, Fenart L, Cecchelli R, et al. Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier. J Pharmacol Exp Ther. 2004;310:745–751.
- Graham DR, Chertova E, Hilburn JM, Arthur LO, Hildreth JE. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol. 2003;77:8237–8248.
- McNeil PL. Repairing a torn cell surface: make way, lysosomes to the rescue. J Cell Sci. 2002;115:873–879.
- Strauss K, Goebel C, Runz H, Moebius W, Weiss S, et al. Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J Biol Chem. 2010;285:26279–26288.
- Colvin RA, Means TK, Diefenbach TJ, Moita LF, Friday RP, et al. Synaptotagmin-mediated vesicle fusion regulates cell migration. Nat Immunol. 11:495–502.
- Chen FW, Gordon RE, Ioannou YA. NPC1 late endosomes contain elevated levels of non-esterified (‘free’) fatty acids and an abnormally glycosylated form of the NPC2 protein. Biochem J. 2005;390:549–561.
- Higgins ME, Davies JP, Chen FW, Ioannou YA. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab. 1999;68:1–13.
- Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ. Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet. 2001;68:14–25.
- McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, et al. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol. 1995;46:153–185.
Source: PubMed